What the Two-Year Delay on Generic Drug Tariffs Says About Onshoring

President Trump's plan to impose tariffs on generic drugs includes an unexpected two-year delay until 2028. Lucas and Luna examine why the administration pushed back the timeline, what it reveals about America's onshoring progress, and how pharmaceutical imports—worth over $100 billion annually—factor into the widening US trade deficit. With the trade gap hitting -77.6 billion in May 2026, the hosts discuss whether the delay is a pragmatic pause or a concession that domestic production isn't ready. Tied to recent headlines and the strong dollar's effect on import prices, this episode drills into a specific policy move with big implications for the trade balance. #GenericDrugTariffs #DrugTariffs #Onshoring #TradeDeficit #PharmaceuticalImports #USChinaTrade #TradePolicy #Economics #TrumpAdministration #ImportPrices #SupplyChain #FexingoBusiness #BusinessPodcast #EconomicsPodcast #TradeDeficitPodcast #LucasAndLuna #CurrentAffairs #BusinessPodcasting Keep every episode free: buymeacoffee.com/fexingo